CSNK2B and cholangiocarcinoma: These data are in agreement with a previous study that reported overexpression of the CK2α and CK2β genes in several types of lethal cancers including hepatocellular carcinoma32, and with data proposing a correlation between overexpression of CK2β and CCA progression33.